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Keywords:
Western Equine Encephalitis virus
Virulencequine Encephalitis (WEE) in humans and equids peaked during the mid-20th
century and has declined to fewer than 1–2 human cases annually during the past 20 years. Using the mouse
model, changes in WEE virus (WEEV) virulence were investigated as a potential explanation for the decline in
the number of cases. Evaluation of 10 WEEV strains representing a variety of isolation locations, hosts, and all
decades from the 1940's to the 1990's yielded no evidence of a decline in virulence. These results suggest that
ecological factors affecting human and equine exposure should be investigated to explain the decline in WEE.
© 2008 Elsevier Inc. All rights reserved.IntroductionWestern Equine Encephalitis Virus (WEEV) is a mosquito-borne
Alphavirus (family Togaviridae) that causes severe neurological disease
in humans and equids. Infection can result in mild to severe
neurologic sequelae in human survivors, and has an economic impact
ranging from $21,000 to $3 million dollars per case (CDC,1995). WEEV
is found in western North America and South America, and within
western North America utilizes a mosquito–bird cycle with Culex
tarsalis as the primary vector, although some refractory populations of
this species have been described. Since the discovery ofWEEV in 1930,
it has caused epidemics in equids and humans across the western half
the U.S. and Canada, with the attack rate in humans reaching as high
as 50/100,000 in Kern county, California (Reeves and Hammon, 1958).
Overall, the estimated case fatality rate in humans is 3–4% (Reisen and
Monath, 1988). The number of human and equine cases peaked in the
1940's and 1950's and has subsequently declined. Speciﬁcally, from
1964 to 1985 there was a total of 587 human WEE cases, while from
1986 to 2006 there were only 67 human cases documented (CDC,
2005). This decrease in cases is in stark contrast to the numerous
emerging infectious diseases identiﬁed during the latter half of the
20th century, including several arthropod-borne viral diseases of
North America (Fauci, 2001), raising the question of whyWEE appears
to be declining. In spite of the decline in cases, WEE is still a notiﬁable
disease and under the right circumstances it is possible that the virus
may cause further epidemics. Understanding the reasons for the
decline in WEE could elucidate factors involved in the decline of this
and emergence of other arboviruses.l rights reserved.One hypothesis for the decrease in WEE is that the extant viruses
are less virulent than the now-extinct virus lineages isolated during
the period of peak epidemicity, perhaps as a result of unidentiﬁed
selective pressures acting on WEEV or founder effects. However, a
recent study identiﬁed no difference among California WEEV strains
from different decades of the 20th century in avian viremia or
virulence, or in infectivity for Cx. tarsalis (Reisen et al., 2008). There
are other possible enzootic hosts for WEEV such as the blacktail
jackrabbit (Lepus californicus), and these have not yet been tested for
altered responses to WEEV isolated during different time periods.
Other possible ecological explanations for the reduction in WEE cases
include the decline in uses of equids in agriculture, declining
populations of the primary vectors (Cx. tarsalis and Aedes dorsalis)
and/or changing vertebrate host populations. Another hypothesis for
the WEE decline is that, due to stochastic genetic changes in WEEV or
selection by hosts not yet examined, virulence for equids and
humans has decreased. To test this hypothesis and to deﬁne a robust
animal model for vaccine testing, we compared the virulence of 10
strains of WEEV isolated from the 1940's through to the 1990's using
a mouse model.
Results
The murine virulence of each WEEV strain was measured as the
presence and level of viremia in the serum of the blood on day 1
postinfection (p.i.), the weight loss exhibited over the course of
infection, and the percentage survival. The viremia levels are shown in
Table 1. The mice were bled on day one p.i. because pilot studies (data
not shown) had demonstrated that viremia was undetectable after
this time point. There was no discernable correlation (Wilcoxon's
ranked test) between the level and presence of viremia and the year of
isolation of the WEEV strains (p=0.5).
Table 1
Viremia levelsa 1 day after infection with WEEV
Virus
strain
CA46 MO50 CA53 MT67 CA68 TX71 CA83 NM85 CO92 AZ93
Mouse 1 b1.7 b1.7 2.11 b1.7 b1.7 b1.7 b1.7 b1.7 b1.7 b1.7
Mouse 2 1.81 b1.7 b1.7 b1.7 b1.7 b1.7 b1.7 b1.7 b1.7 b1.7
Mouse 3 b1.7 b1.7 2.52 3.60 2.18 b1.7 b1.7 b1.7 3.74 b1.7
Mouse 4 b1.7 b1.7 b1.7 3.48 b1.7 b1.7 b1.7 2.54 b1.7 b1.7
a Titers expressed as log10 pfu/ml. Animals were considered negativewhen below the
detection limit of 1.7 log10 pfu/ml.
Fig. 1. (a) Percentage survival and rate of progression to mortality in Swiss–Webster
mice injected with 3 log10 pfu/ml s.c. in 50 ul and (b) average change in weight (grams)
over the course of the experiment with the date of infection set as zero. Bars indicate
standard deviations of the means.
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the data are presented in Fig. 1. The survival proﬁles (Fig. 1b), showed
little correlation between the date of WEEV collection and the
percentage or mean days of survival (p=0.3). Indeed, strains MT67
and CA53, as well as MO50, showed either severe weight loss and no
mortality or slight weight loss and somemortality, suggesting that the
ability of the virus to induceweight loss is not necessarily predictive of
mortality. In fact, the only WEEV strain that showed both consistent
weight loss and high mortality was CA46, although the viremia
produced by this strain was minimal.
For 4 of theWEEV strains (TX71, CA46, CA53 &MO50), organs were
collected on day 7 p.i. and virus titers were determined. For all 4
strains, the brain was positive with titers ranging from 7.2×108 to
1.5×1010 pfu/g. For strains CA53 and MO50, virus was only found in
the brain, whereas strains CA46 and TX71 were also present in the
spleen (CA46) or the lung and the liver (TX71). There was very little
difference in titers among the WEEV strains.
Statistical tests
The viruses were ranked by weight loss, presence/absence and
level of viremia, percentage survival and date of collection. The
Wilcoxon Ranked Test indicated no signiﬁcant correlations between
viremia, weight loss and survival (mortality rate and mean survival
time). The strongest correlation between year of WEEV collection and
virulence was observed for weight loss. However, this was not
signiﬁcant at the 95% conﬁdence interval (p=0.3).
Discussion
WEEV typically circulates enzootically between birds and the
mosquitoes Cx. tarsalis and Ae. dorsalis as well as other members of
the Dorsalis complex such as Ae. melanimon and Ae. campestris. A
recent study that examined recent and older WEEV isolates in these
hosts indicated no consistent differences in strains isolated during
different decades and fromdifferent regions of California (Reisen et al.,
2008). However, potential differences in hosts involved in a secondary
transmission cycle between the blacktail cottontail and Ae.melanimon
(Hardy, 1987), which may contribute to WEEV maintenance, have not
been examined. Furthermore, the dead-end hosts that generally
indicate the occurrence of WEE epizootics, equids and humans, may
respond to WEEV strains in ways not indicated by avian infections.
Therefore, we used mice as a model for mammalian virulence.
Previous murine model studies utilized the Argentinean strains
and the McMillan strain of WEEV (Bianchi et al., 1993; Nagata et al.,
2006). The Argentinean strains represented by Ag80-646 probably
circulate in a distinct ecosystem from the North American strains
(Bianchi et al., 1997; Calisher et al., 1985) and therefore they were not
included in our study as they are unlikely to have much bearing on the
decline in virulence ofWEEV in North America. Additionally, the route
of infection in the previous studies was intranasal (i.n.), intracranial
(i.c.) or intraperitoneal (i.p.) (Hardy et al., 1997). In our experience,
WEEV is nearly always fatal via the i.n. and i.c. routes (data not shown).
We hoped to develop a system that was closer to natural mosquito-
borne infection, and as such the s.c. route was utilized.The strains selected for this study were taken from the group
B clade of theWEEV as deﬁned byWeaver et al. (1997), with the strain
TX71 included as a control strain from outside the group. Strains
M050, CA46 and CA53 were taken from a subclade that had limited
virus isolates from the later decades, whereas the rest of the strains
were from a more variable and long-lived lineage. There was no
reproducible difference in virulence between the two subclades, as
deﬁned by viremia or survival. In all of the statistical tests performed,
there was no obvious correlation between year of isolation and any
measure of viremia that was used. Weight loss correlated well with
the date of collection (Spearman's correlation coefﬁcient r=0.002),
although the results were not signiﬁcant underWilcoxon's ranked test
(p=0.3). This indicates that more WEEV strains and/or larger mouse
cohort sizes may be needed to increase the power of the study, or a
different animal model.
To date, no experimentally supported hypothesis has been
suggested for the decline in WEE. However possible ecological
changes should also be considered. Interestingly, unlike WEEV, the
closely related avian alphavirus, eastern equine encephalitis virus
(EEEV) has not shown the same trend of decreasing incidence, and
until the introduction of West Nile virus, neither had the ecologically
similar avian ﬂavivirus, St. Louis encephalitis virus (SLEV) (Fang and
Reisen, 2006; Hachiya et al., 2007). It is possible that the ecological
changes unique to the WEEV transmission cycle could explain this
discrepancy. One such possibility is the decline in the use of equids on
farms in the U.S. during the past century, coincident with the
industrialization of agriculture (Reisen and Monath, 1988). However,
equids are not considered ampliﬁcation hosts so their abundance
should not affect human exposure. Other possible explanations for the
decline in human exposure are social trends that limit mosquito
exposure, such as the increase in air conditioning (Gahlinger et al.,
Table 2
WEEV strains used in this study, the date and place of collection, the source of isolation
and the passage history
Code Strain Place of origin Year Host Passage history
CA46 BFS932 Bakersﬁeld, CA 1946 Culex tarsalis sm1
MO50 Ep-6 Missouri 1950 Mosquito ce1
CA53 BFS1703 California 1953 Culex tarsalis sm1/C6/36 1
MT67 Montana 64 Montana 1967 Horse de1
CA68 S8 1-22 Paradise (Butte Co) 1968 Sciurus griseus sm1
TX71 TBT-235 Texas 1971 Gopherus berland wc1,de1,sm1
CA83 CHLV 53 Riverside Co., CA 1983 Culex tarsalis vero1
NM85 85-452-NM New Mexico 1985 Culex tarsalis sm2
CO92 CO92-1356 Larimer City, CO 1992 Culex tarsalis vero1
AZ93 93A-27 Parker, Arizona 1993 Mosquito vero1
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change in the distribution of the mosquito vectors Cx. tarsalis and Ae.
dorsalis should also be evaluated, as any component of the enzootic
transmission cycle may limit the number of spillover cases. Also, the
western part of the U.S., particularly Colorado and California, were
drier in the latter part of the 20th Century (Karl et al., 1995) and this
may have contributed to a decline in WEEV transmission. It is
important to determine the reasons for the decline in WEEV, as the
mechanisms that have contributed to this decline could change in the
future, affecting the circulation and disease caused by this and/or
other arboviruses.
Materials and methods
Virus strains
TheWEEV strains used for this study were chosen because of their
low passage histories and their isolation from a variety of hosts and
locations. All 10 strains came from the group B WEEV clade (Weaver
et al., 1997), the only North American clade known to persist since the
1970's. The strain details are found in Table 2. Because the host cell of
origin can affect alphavirus pathogenesis (Shabman et al., 2007), all
virus stocks were prepared in C6/36 cells with 3 days of incubation at
32 °C. Viruses were harvested and stored with a ﬁnal concentration of
20% fetal bovine serum (FBS) at −80 degrees.
Virulence assays
Swiss–Webster mice (Charles Rivers, Wilmington, MA 01887, USA)
were used as amodel forWEEbecause pilot studies (unpublished data)
had determined that this strain of outbred mice was the most
susceptible to severe disease. Mouse manipulations were carried out
using a protocol approved by theUTMB IACUC. The route of inoculation
and dosewere chosen to approximate amosquito bite and because this
model was also developed for vaccine efﬁcacy studies.
Mice were infected subcutaneously with 103 plaque forming units
(pfu) of virus in a 50 μl volume. Animals were bled via the retroorbital
sinus on day one postinfection and the serum was diluted 1:10 in
phosphate buffered saline (PBS) and stored at −80 °C. Mouse serum
was tested for the presence of WEEV using a standard plaque assay on
Vero cells (Beaty, Calisher, and Shope, 1989). Animals were monitored
daily for signs of disease, and were weighed daily from day 3–14 or 17
after infection.
For 4 of the WEEV strains (TX71, MO50, CA46, CA53), surviving
mice sacriﬁced on day 7 after infection or at the point of death were
necropsied, then organs were homogenized in PBS to prepare 10% W/V suspensions and tested for WEEV using cytopathic effect (CPE)
assays on Vero cells, followed by titration using a plaque assay.
The resulting datasets were ranked using semi-quantitative levels
of virulence and tested using Wilcoxon's ranked test for correlations
between the date of collection and the virulence of the WEEV strains.
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